Hercules Capital, Inc.

Equities

HTGC

US4270965084

Investment Management & Fund Operators

Real-time Estimate Cboe BZX Other stock markets 03:15:23 2024-05-17 pm EDT			5-day change	1st Jan Change
19.42 ^USD	+1.81%		-2.41%	+16.50%

04:35pm	UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating	MT
May. 15	Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital	MT

Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024

April 30, 2024 at 06:00 am EDT

Hercules Capital, Inc. announced that its Board of Directors has declared a first quarter 2024 total cash distribution of $0.48 per share. The following shows the key dates of the first quarter 2024 distribution payment: Record date is on May 14, 2024 and payment date is on May 21, 2024.

Latest news about Hercules Capital, Inc.

UBS Adjusts Price Target on Hercules Capital to $18.50 From $18, Maintains Neutral Rating	10:35am	MT
Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital	May. 15	MT
X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise	May. 09	MT
Verona Pharma Signs Financing Agreements for Up to $650 Million	May. 09	MT
Transcript : Hercules Capital, Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024	Apr. 30	CI
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment	Apr. 30	MT
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million.	Apr. 02	CI
Bluebird bio to Restate Financial Statements; Shares Fall	Mar. 26	MT
JMP Securities Adjusts Hercules Capital Price Target to $19 From $18, Maintains Market Outperform Rating	Mar. 26	MT
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon	Mar. 18	MT
Sector Update: Health Care	Mar. 18	MT
Bluebird bio Secures $175 Million Term Loan Facility	Mar. 18	MT
Health Data Vision, Inc. announced that it has received $65 million in funding from Hercules Capital, Inc.	Feb. 25	CI
Piper Sandler Raises Price Target on Hercules Capital to $20 From $18.50, Maintains Overweight Rating	Feb. 16	MT
Hercules Capital Posts Increased Q4 Net, Total Investment Income	Feb. 15	MT
Transcript : Hercules Capital, Inc., Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
Hercules Capital, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Hercules Capital, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Wheat Futures Fall as Russian Export Prices Sink -- Daily Grain Highlights	Feb. 15	DJ
Hercules Capital Declares Q4 Supplemental Cash Distribution of $0.08 a Share, Payable March 6 to Shareholders of Record Feb. 28	Feb. 13	MT
Hercules Capital, Inc. Declares Cash Distribution for the Fourth Quarter 2023, Dividend Payable on March 6, 2024	Feb. 13	CI
Hercules Capital Announces New Supplemental Cash Distribution of $0.32 Per Share, Payment on March 6, 2024	Feb. 13	CI
Haveli Investments Software Fund I, L.P., a fund managed by Haveli Investment Management LLC entered into an Agreement and Plan of Merger to acquire ZeroFox Holdings, Inc. (NasdaqGM : ZFOX) from Monarch Alternative Capital LP and Others for approximately $150 million.	Feb. 05	CI

Chart Hercules Capital, Inc.

Duration

Period

More charts

Company Profile

Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing financing solutions to venture capital-backed and institutional-backed companies in a variety of technology, life sciences and sustainable and renewable technology industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments in primarily Structured Debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including, computer software and hardware, networking systems, semiconductors, semiconductor capital equipment, information technology infrastructure and others.

Sector

Investment Management & Fund Operators

Calendar

2024-06-20 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Hercules Capital, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

19.07 USD

Average target price

19.75 USD

Spread / Average Target

+3.57%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Venture Capital

	1st Jan change	Capi.
HERCULES CAPITAL, INC.	+16.50%	3.05B
UMBRA COMPANIES INC.	+12.82%	1.77B
HBM HEALTHCARE INVESTMENTS AG	+9.42%	1.51B
OCTOPUS TITAN VCT PLC	-11.54%	1.2B
MOLTEN VENTURES PLC	+16.35%	737M
CION INVESTMENT CORPORATION	+10.11%	670M
VERUSA HOLDING	+31.22%	552M
OCTOPUS APOLLO VCT PLC	-4.17%	503M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+27.48%	480M
BITCOIN GROUP SE	+73.57%	321M

Venture Capital